Trials / Completed
CompletedNCT00144092
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma
High Dose Chemotherapy and Autologous or Allogeneic Blood Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Alberta Health services · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Low grade lymphoma patients receive R-ICE reinduction therapy followed by allogeneic stem cell transplanation.
Detailed description
Low grade lymphoma patients receive R-ICE reinduction therapy followed by allogeneic stem cell transplanation if they have an HLA matched sibling, or an autologous transplant if they do not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | stem cell source |
Timeline
- Start date
- 2001-05-01
- Completion
- 2010-06-01
- First posted
- 2005-09-05
- Last updated
- 2011-11-21
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00144092. Inclusion in this directory is not an endorsement.